CIN2, p16INK4a, HPV E4, molecular biomarker, risk stratification
Showing 1 - 25 of >10,000
Predictive for Cervical Intraepithelial Neoplasia Grade 2
Active, not recruiting
- Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
-
Herning, Region Of Central Jutland, DenmarkDepartment of Gynecology and Obstetrics, Herning Regional Hospit
Sep 9, 2021
Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in
Recruiting
- DCIS
-
Victoria, British Columbia, Canada
- +9 more
Jan 31, 2023
Oropharyngeal Squamous Cell Carcinoma Trial in Worldwide (Radiation, Cisplatin, Durvalumab)
Recruiting
- Oropharyngeal Squamous Cell Carcinoma
- Radiation
- +3 more
-
Brussels, Belgium
- +25 more
Aug 8, 2022
Cervix Cancer, HPV Testing, Postmenopausal Women Trial in Randers (cytology, p16/ki67 dual stain cytology (DS), extended
Recruiting
- Cervix Cancer
- +2 more
- cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load,
-
Randers, Central Denmark Region, DenmarkDepartment of Pathology
Feb 3, 2023
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute
Recruiting
- Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
- +9 more
- Cytarabine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2021
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Cervix Uteri SIL, HPV, CIN2 Trial in Prague (Colposcopy)
Recruiting
- Cervix Uteri SIL
- +3 more
- Colposcopy
-
Prague, CzechiaGeneral University Hospital
Nov 24, 2023
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL Trial in Worldwide (VGX-3100, Placebo,
Completed
- Cervical Dysplasia
- +2 more
- VGX-3100
- +2 more
-
Tucson, Arizona
- +52 more
Oct 13, 2022
Cervical Intraepithelial Neoplasia Grade 2/3, Cervical Lesion Trial in Hangzhou (TCT test, Vaginoscopy, High throughput HPV
Recruiting
- Cervical Intraepithelial Neoplasia Grade 2/3
- Cervical Lesion
- TCT test
- +3 more
-
Hangzhou, Zhejiang, ChinaWomen's hospital school of medicine zhejiang university
May 5, 2023
Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV Trial
Recruiting
- Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
- +3 more
- Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
-
L'Hospitalet De Llobregat, Catalunya, SpainGynaecology Unit, Bellvitge University Hospital (HUB)
Jan 24, 2023
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Neonatal Sepsis Trial in Cincinnati (Renal Angina Index (RAI))
Not yet recruiting
- Acute Kidney Injury
- +2 more
- Renal Angina Index (RAI)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jan 25, 2023
Papilloma Viral Infection, CIN1, LSIL, Low Grade Squamous Intraepithelial Lesion Trial in Madrid (Glizigen, Placebo)
Recruiting
- Papilloma Viral Infection
- +2 more
- Glizigen
- Placebo
-
Madrid, Spain
- +3 more
Jun 27, 2023
Cervix Cancer, HPV Infection, Cervical High Grade Squamous Intraepithelial Lesion Trial in São Paulo, Cuernavaca (Xpert HPV, S5
Recruiting
- Cervix Cancer
- +3 more
- Xpert HPV
- S5 DNA methylation classifier
-
São Paulo, Brazil
- +1 more
Aug 14, 2023
Vulvar Cancer Trial in Vancouver (Re-excision)
Not yet recruiting
- Vulvar Cancer
- Re-excision
-
Vancouver, British Columbia, CanadaBC Cancer - Vancouver Centre
Oct 8, 2022
Meningioma Trial in Heidelberg (Explorative biomarker study)
Not yet recruiting
- Meningioma
- Explorative biomarker study
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Oct 23, 2023
Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)
Not yet recruiting
- Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
- Monalizumab
- Cetuximab
- (no location specified)
Jan 8, 2023
Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)
Not yet recruiting
- HPV Infection
- Urine Sample Collection
- +2 more
-
Dhaka, Bangladesh
- +7 more
Nov 10, 2023
Plasma MRD and cfDNA HPV and Efficacy and Prognosis of Locally
Recruiting
- Locally Advanced Cervical Cancer
- Concurrent chemoradiotherapy
-
Guiyang, Guizhou, ChinaYong Li
Jul 14, 2023
Cervical Cancer, Prevention Trial in Ramotswa (Automated visual evaluation)
Active, not recruiting
- Cervical Cancer
- Prevention
- Automated visual evaluation
-
Ramotswa, BotswanaBamalete Lutheran Hospital
Feb 1, 2023
Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Sao Paulo (cisplatin, gemcitabine, Follow-up)
Not yet recruiting
- Cervical Cancer
- +2 more
- cisplatin, gemcitabine
- Follow-up
-
Sao Paulo, BrazilHospital do Coração - Research Institute
Mar 1, 2023
Kidney Transplant Trial in Canada, United States (Abatacept, Standard of Care at US Transplant Centers)
Not yet recruiting
- Kidney Transplant
- Abatacept
- Standard of Care at US Transplant Centers
-
Birmingham, Alabama
- +19 more
Jun 20, 2023
stratification of High-risk Intestinal Metaplasia (GCEP2 Study)
Recruiting
- Stomach Neoplasm
- Blood Collection, processing and analyses
- +2 more
-
Stanford, California
- +7 more
Mar 13, 2023
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL Trial in Worldwide (VGX-3100, Placebo,
Completed
- Cervical Dysplasia
- +2 more
- VGX-3100
- +2 more
-
Mesa, Arizona
- +59 more
Dec 6, 2021
HIV, HPV - Anogenital Human Papilloma Virus Infection Trial in Bobo-Dioulasso, Phnom Penh, Abidjan (HPV test with partial
Recruiting
- HIV Infections
- HPV - Anogenital Human Papilloma Virus Infection
- HPV test with partial genotyping and VIA triage
-
Bobo-Dioulasso, Burkina Faso
- +2 more
Feb 15, 2022
Cervix Dysplasia, HPV Infection Trial in Herne (DEFLAGYN vaginal gel)
Not yet recruiting
- Cervix Dysplasia
- HPV Infection
- DEFLAGYN vaginal gel
-
Herne, North Rhine-Westphalia, GermanyMarien Hospital Herne
Aug 19, 2022